Skip to main content
. 2020 Jan 16;13:525–540. doi: 10.2147/OTT.S224465

Figure 3.

Figure 3

Schematic representation of the key CSC signalling pathways TGF-β, JAK/STAT3, and Nf-κB. Some of the current drugs targeting these pathways in CSCs are shown.

Abbreviations: TGF-β, transforming growth factor-β; R-Smad, receptor-regulated Smad; Co-Smad, common Smad; JAK, Janus kinase; STAT, signal transducer and activator of transcription; NF-κB, nuclear factor kappa-B; IκB, inhibitor of NF-κB; IKK, inhibitor of NF-κB kinase.